First Turn Management »

Ideaya Biosciences shares owned by First Turn Management

Quarter-by-quarter ownership of Ideaya Biosciences (IDYA) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Ideaya Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ideaya Biosciences held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ideaya Biosciences by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $14M 382k 35.58

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Ideaya Biosciences

Federated Investors
T. Rowe Price Associates
Henderson Group
Vanguard Group
Deerfield Management Company
Boxer Capital
Logos Global Management
BVF
Holocene Advisors
Citadel Advisors
Avidity Partners Management
Dimensional Fund Advisors
Fiera Capital Corporation
Baker Bros. Advisors
Redmile Group

View all funds holding Ideaya Biosciences